Mettler-Toledo International (NYSE:MTD) Price Target Cut to $1,125.00 by Analysts at Wells Fargo & Company

Mettler-Toledo International (NYSE:MTD) had its price objective dropped by equities researchers at Wells Fargo & Company from $1,400.00 to $1,125.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The brokerage presently has an “equal weight” rating on the medical instruments supplier’s stock. Wells Fargo & Company‘s price objective would suggest a potential upside of 11.43% from the stock’s current price.

A number of other equities research analysts have also recently commented on the stock. Citigroup upgraded shares of Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,400.00 target price for the company in a research report on Monday, April 7th. Robert W. Baird raised their price objective on shares of Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the stock a “neutral” rating in a research report on Monday, February 10th. Finally, Evercore ISI raised their price target on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an “outperform” rating in a report on Monday, February 10th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and four have given a buy rating to the company. According to data from MarketBeat, Mettler-Toledo International presently has a consensus rating of “Hold” and an average target price of $1,346.13.

Mettler-Toledo International Stock Down 0.7 %

Shares of NYSE:MTD traded down $7.02 during trading on Thursday, reaching $1,009.63. 107,166 shares of the company’s stock traded hands, compared to its average volume of 140,196. The firm has a market cap of $21.04 billion, a PE ratio of 24.98, a P/E/G ratio of 3.30 and a beta of 1.28. The company has a 50-day simple moving average of $1,198.65 and a 200-day simple moving average of $1,268.28. Mettler-Toledo International has a fifty-two week low of $946.69 and a fifty-two week high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 EPS for the quarter, topping the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. On average, equities research analysts forecast that Mettler-Toledo International will post 42.71 EPS for the current year.

Insider Activity

In other Mettler-Toledo International news, insider Christian Magloth sold 790 shares of the business’s stock in a transaction on Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the transaction, the insider now directly owns 734 shares of the company’s stock, valued at approximately $964,248.46. The trade was a 51.84 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Gerry Keller sold 600 shares of the firm’s stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $1,351.34, for a total transaction of $810,804.00. Following the completion of the sale, the insider now owns 6 shares of the company’s stock, valued at approximately $8,108.04. The trade was a 99.01 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.94% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of MTD. GAMMA Investing LLC raised its position in Mettler-Toledo International by 131,246.3% during the first quarter. GAMMA Investing LLC now owns 386,158 shares of the medical instruments supplier’s stock worth $456,018,000 after acquiring an additional 385,864 shares during the last quarter. Norges Bank purchased a new stake in Mettler-Toledo International during the 4th quarter worth about $372,954,000. Proficio Capital Partners LLC purchased a new position in Mettler-Toledo International in the 4th quarter valued at about $163,216,000. T. Rowe Price Investment Management Inc. raised its position in shares of Mettler-Toledo International by 36.1% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 363,107 shares of the medical instruments supplier’s stock valued at $444,327,000 after buying an additional 96,300 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA grew its stake in Mettler-Toledo International by 53.0% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 214,281 shares of the medical instruments supplier’s stock worth $262,211,000 after acquiring an additional 74,187 shares during the period. Institutional investors and hedge funds own 95.07% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.